A three-judge panel of the 5th U.S. Circuit Court of Appeals in New Orleans will hear arguments Wednesday in a case that could decide the future availability of the abortion pill mifepristone. Attorneys for the FDA and the drug's manufacturer will attempt to convince the panel not to roll back accessibility to the drug, which has been used by millions of women in the U.S. and around the world. The outcome of the case could have a major impact on the availability of the drug and could affect the lives of millions of women.